NEFH and proximal spinal muscular atrophy: Additionally, on a molecular level, phosphorylated neurofilament heavy chain (p-NF-H) levels have been shown to be a potential biomarker of disease severity and treatment response in SMA patients who received nusinersen treatment symptomatically [192,206,207].